Doctors exposed to multichannel content, demonstrate a 50% higher likelihood of diversifying their prescription portfolio: CLIRNET Survey

• Survey reveals a paradigm shift in medical decision-making and underscores the growing importance of diverse information sources in shaping prescription patterns.

• Oncologists reported Real World Evidence (RWE) significantly impacted their treatment choices

CLIRNET, a leading digital Continuing Medical Education (CME) platform established in 2017, has unveiled groundbreaking findings from an extensive study on the influence of Real-World Evidence (RWE) and online content consumption on prescription choices among healthcare professionals (HCPs). The research reveals a paradigm shift in medical decision-making and underscores the growing importance of diverse information sources in shaping prescription patterns.

The report highlights:

• 72% of HCPs reported RWE significantly impacted their treatment choices, particularly for chronic diseases. This trend is even more pronounced in oncology.
• HCPs who engage with patient case studies are 60% more likely to prescribe evidence-based therapies with proven real-world efficacy. This underscores the power of relatable, real-world illustrations in influencing clinical decisions.
• Doctors exposed to multichannel content, including articles, videos, and podcasts, demonstrate a 50% higher likelihood of diversifying their prescription portfolio. This highlights the value of varied content strategies in medical marketing.
• The study shows a 45% higher chance of prescription changes among doctors engaged in scientific webinars, highlighting the value of interactive learning.
• RWE boosts targeted therapies in oncology and aids rare disease treatments, enhancing outcomes and offering hope for limited options.

The study showcases that content patterns offer pharmaceutical & medical devices companies a chance to refine HCP engagement and influence prescription decisions through tailored strategies.

Commenting on the findings, Saurav Kasera, Co – Founder and CEO, CLIRNET, said, “Our groundbreaking study highlights how RWE and targeted content are reshaping prescription patterns. Data shows healthcare professionals increasingly depend on RWE for treatment decisions, especially in oncology and chronic diseases. We found a strong link between diverse content consumption and prescription diversity, emphasizing the need for multifaceted medical education. Our research offers a roadmap to bridge clinical trials and real-world practice, shaping the future of healthcare.”

CLIRNET’s study shows RWE’s impact and challenges, recommending better data sources and collaboration to improve patient care. This study reveals RWE’s critical role in guiding medical education and content marketing strategies.